CD163 and neoplasm: While some studies have observed no prognostic role, in others both the number of CD68+ cells and soluble CD163 have correlated to poor overall survival (OS); however, only CD68+ cell counts at the invasive front of the tumour have been found to be independent predictors of reduced survival.6–9